Carregant...
Fitxers
Tipus de document
ArticleVersió
Versió publicadaData de publicació
Llicència de publicació
Si us plau utilitzeu sempre aquest identificador per citar o enllaçar aquest document: https://hdl.handle.net/2445/117328
HIV-1 DNA predicts disease progression and post-treatment virological control
Títol de la revista
Director/Tutor
ISSN de la revista
Títol del volum
Recurs relacionat
Resum
In HIV-1 infection, a population of latently infected cells facilitates viral persistence despite antiretroviral therapy (ART). With the aim of identifying individuals in whom ART might induce a period of viraemic control on stopping therapy, we hypothesised that quantification of the pool of latently infected cells in primary HIV-1 infection (PHI) would predict clinical progression and viral replication following ART. We measured HIV-1 DNA in a highly characterised randomised population of individuals with PHI. We explored associations between HIV-1 DNA and immunological and virological markers of clinical progression, including viral rebound in those interrupting therapy. In multivariable analyses, HIV-1 DNA was more predictive of disease progression than plasma viral load and, at treatment interruption, predicted time to plasma virus rebound. HIV-1 DNA may help identify individuals who could safely interrupt ART in future HIV-1 eradication trials.
Matèries (anglès)
Citació
Col·leccions
Citació
WILLIAMS, James p., HURST, Jacob, STÖHR, Wolfgang, ROBINSON, Nicola, BROWN, Helen, FISHER, Martin, KINLOCH, Sabine, COOPER, David a., SCHECHTER, Mauro, TAMBUSSI, Giuseppe, FIDLER, Sarah, CARRINGTON, Mary, BABIKER, Abdel, WEBER, Jonathan, KOELSCH, Kersten k., KELLEHER, Anthony d., PHILLIPS, Rodney e., FRATER, John, MIRÓ MEDA, José m. (josé maría), GATELL, José m., SPARTAC Trial Investigators. HIV-1 DNA predicts disease progression and post-treatment virological control. _eLife_. 2014. Vol. 3, núm. e03821. [consulta: 24 de gener de 2026]. ISSN: 2050-084X. [Disponible a: https://hdl.handle.net/2445/117328]